Market Overview:
The global cell surface marker market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for flow cytometers, hematology analyzers, and reagents and kits for cell surface marker analysis. In addition, the growing prevalence of cancer and other diseases is also contributing to the growth of this market. The global cell surface marker market by type is segmented into flow cytometers, hematology analyzers, reagents and kits. The flow cytometer segment is expected to grow at a CAGR of 8% from 2018 to 2030 due to the increasing demand for these instruments in hospitals and laboratories worldwide. The hematology analyzer segment is projected to grow at a CAGR of 6% from 2018-2030 due its ability detect various types of blood cells including white blood cells (WBCs), red blood cells (RBCs), platelets etc.
Product Definition:
A cell surface marker is a protein that is found on the outer surface of a cell. They are important for cell-to-cell communication and can be used to identify different types of cells.
Flow Cytometer:
Flow cytometry is a technique to measure the expression level of cell surface markers by analyzing the cellular behavior in a fluid stream. It provides valuable insights on cell biology and molecular biology, which are not possible through other conventional techniques. Flow cytometry has applications in immunology, cancer research, stem cell research as well as drug discovery & development studies.
Hematology Analyzers:
Hematology analyzers are instruments used for analyzing the blood count and different types of cellular elements in the blood. It is a branch of clinical laboratory science that deals with the study of the effect of hematological factors on disease occurrence, prevention, diagnosis, and treatment. Hematology analyzers have different applications such as drug discovery & development (R&D), biotechnology companies performing research activities or medical device manufacturing companies involved in preclinical studies or clinical trials.
Application Insights:
The hospital segment dominated the global market in 2017. The application of cell surface markers has witnessed a rise in hospitals across the world. This can be attributed to growing awareness about better diagnosis and treatment of diseases, increasing government funding for research and development on new drugs, and an increase in spending power by patients with chronic conditions who seek medical care at advanced stages.
Cell surface markers are used for various purposes such as tumor screening, monitoring response to therapy, follow up after surgery or chemotherapy etc. They are also used before major surgeries so that surgeons have enough information about a patient¢â‚¬â„¢s immune system before undertaking any major operation or procedure that may require immunosuppression such as heart transplantation etc., which is expected to propel growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing adoption of technologically advanced products. Moreover, growing focus on quality standards by government agencies such as FDA and WHO is expected to drive growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising healthcare expenditure coupled with increasing prevalence of cancer & diabetes among others diseases that require sophisticated diagnostic tools for proper management.
Major companies operating in this industry include BioXpert International GmbH; C2DX Biosciences; CellTraffix LLC; Corning Inc.
Growth Factors:
- Increasing prevalence of cancer and other diseases that require cell surface marker identification for diagnosis and treatment will drive the market growth.
- Growing demand for personalized medicine will also spur the demand for cell surface markers.
- Advances in technology that allow for more accurate and rapid detection of cell surface markers will propel market growth.
- The increasing use of monoclonal antibodies as therapeutics is expected to drive the demand for cell surface markers as well5 Increased research funding into biomarkers and their applications is likely to result in new innovations that will fuel market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Surface Marker Market Research Report
By Type
Flow Cytometer, Hematology Analyzers, Reagents and Kits
By Application
Hospital, Laboratory
By Companies
Bio-Rad, Abbott Laboratories, Seimens Healthcare, Beckman Coulter, Roche Diagnostics, BD Biosciences, Nihon Kohden, Luminex, SYSMEX CORPORATION, Bayer, HORIBA ABX SAS, Boule Medical AB, Mindray, Sinnowa, Hui Zhikang
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Cell Surface Marker Market Report Segments:
The global Cell Surface Marker market is segmented on the basis of:
Types
Flow Cytometer, Hematology Analyzers, Reagents and Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Abbott Laboratories
- Seimens Healthcare
- Beckman Coulter
- Roche Diagnostics
- BD Biosciences
- Nihon Kohden
- Luminex
- SYSMEX CORPORATION
- Bayer
- HORIBA ABX SAS
- Boule Medical AB
- Mindray
- Sinnowa
- Hui Zhikang
Highlights of The Cell Surface Marker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Flow Cytometer
- Hematology Analyzers
- Reagents and Kits
- By Application:
- Hospital
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Surface Marker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell surface marker is a protein that is found on the cell surface. It helps to identify the cell type and can be used to track cells in vitro or in vivo.
Some of the major companies in the cell surface marker market are Bio-Rad, Abbott Laboratories, Seimens Healthcare, Beckman Coulter, Roche Diagnostics, BD Biosciences, Nihon Kohden, Luminex, SYSMEX CORPORATION, Bayer, HORIBA ABX SAS, Boule Medical AB, Mindray, Sinnowa, Hui Zhikang.
The cell surface marker market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Surface Marker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Surface Marker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Surface Marker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Surface Marker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Surface Marker Market Size & Forecast, 2020-2028
4.5.1 Cell Surface Marker Market Size and Y-o-Y Growth
4.5.2 Cell Surface Marker Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Flow Cytometer
5.2.2 Hematology Analyzers
5.2.3 Reagents and Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Surface Marker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Surface Marker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Flow Cytometer
9.6.2 Hematology Analyzers
9.6.3 Reagents and Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Flow Cytometer
10.6.2 Hematology Analyzers
10.6.3 Reagents and Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Flow Cytometer
11.6.2 Hematology Analyzers
11.6.3 Reagents and Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Flow Cytometer
12.6.2 Hematology Analyzers
12.6.3 Reagents and Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Flow Cytometer
13.6.2 Hematology Analyzers
13.6.3 Reagents and Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Surface Marker Market: Competitive Dashboard
14.2 Global Cell Surface Marker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 Abbott Laboratories
14.3.3 Seimens Healthcare
14.3.4 Beckman Coulter
14.3.5 Roche Diagnostics
14.3.6 BD Biosciences
14.3.7 Nihon Kohden
14.3.8 Luminex
14.3.9 SYSMEX CORPORATION
14.3.10 Bayer
14.3.11 HORIBA ABX SAS
14.3.12 Boule Medical AB
14.3.13 Mindray
14.3.14 Sinnowa
14.3.15 Hui Zhikang
